Market closed · Next open: Tuesday 9:30 AM ET
Last update: Jul 20, 2026, 5:23 PM ET
Kimberly-Clark Corporation
$108.48 0.12% today
Market Closed

Why Kimberly-Clark Corporation (KMB) stock moved

Updated Jul 21, 2026

Kimberly-Clark Corporation (KMB) shares rose 0.1% to $108.48 as of July 21, 2026, a slight gain from the prior close of $108.35. BestStocks flagged the session as a material change for KMB. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for KMB, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

KMB climbed 0.1% to $108.48

KMB rose 0.1% in its latest session, moving from $108.35 to $108.48.

RiskWeak confidence
Rel. volume
0.5×
Below Avg
Vs peers
No comparable peers
Market cap
$36.0B
NASDAQ
Analyst target
$109
+0.2% vs price
Price chart
Jun 22 – Jul 21
VVVVVV$100$108$115Jun 22Jun 29Jul 7Jul 14Jul 21
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Kimberly-Clark Corporation investors

For Kimberly-Clark Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.1% session move; KMB moved +1.53% from $113.01 to $114.74 on 2026-07-07. Weighing against that: Kimberly-Clark Corporation (KMB) moved -3.05% from $110.18 to $106.82 on 2026-07-14; KMB moved -3.28% from $114.74 to $110.98 on 2026-07-08. Wall Street's consensus price target sits at $108.75, implying +0.2% upside from $108.48. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 14 days out, the next report is the most likely near-term test of the move.

KMB price reaction

KMB last traded at $108.48, up $0.13 (+0.12%) from the previous close of $108.35. The session traded on 0.5× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $100.50 and $114.74, and it currently sits about 56% of the way up that band.

Bullish and bearish analyst opinions on Kimberly-Clark Corporation (KMB)

The consensus analyst price target on Kimberly-Clark Corporation (KMB) is $108.75, 0.2% above the recent $108.48. Over the past 90 days analysts logged 0 upgrades, 4 maintains, and 0 downgrades. Here is how the bullish and bearish cases on KMB line up.

The bullish case

  • Wall Street's consensus price target of $108.75 implies +0.2% upside from $108.48.
  • The Street's most bullish target is $121.00 (+11.5%).
  • Positive 0.1% session move.
  • KMB moved +1.53% from $113.01 to $114.74 on 2026-07-07.
  • Positive price momentum.

The bearish case

  • The most bearish analyst target is $99.00 (-8.7%).
  • Kimberly-Clark Corporation (KMB) moved -3.05% from $110.18 to $106.82 on 2026-07-14.
  • KMB moved -3.28% from $114.74 to $110.98 on 2026-07-08.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $109+0.2%
= 4 maintains
UBS maintained Neutral · 2026-07-16
SEC filings watch
8-K2026-05-14
Material event — review for impact
high
8-K2026-05-05
Material event — review for impact
high
10-Q2026-04-28
Quarterly financial results
medium
8-K2026-04-28
Material event — review for impact
high
Peer context
KMB+0.1%

Previous notable changes for KMB

Risk2026-07-08-3.3%
KMB moved -3.28% from $114.74 to $110.98 on 2026-07-08.
Activity2026-07-07+1.5%
KMB moved +1.53% from $113.01 to $114.74 on 2026-07-07.
Valuation2026-07-02+2.9%via Seeking Alpha
Kimberly-Clark spun off its tissue and hygiene business as Arbex, a new independent global leader, which commenced operations today. The spin-off formalizes KMB's transformation into a focused consumer health company.
Valuation2026-07-01+1.5%via Seeking Alpha
KMB rose 1.04% to $110.92 on light volume (0.69x expected). A Seeking Alpha analyst published a note rating KMB a Buy and disclosing it as their largest non-commodities portfolio holding after accumulating shares during a 30% pullback from all-time highs.
Upcoming catalysts & outlook
Next earnings
2026-08-04 (est.)
in 14 days
Earnings Release
2026-08-04
High impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
High
from change events

Frequently asked questions about KMB

Why did Kimberly-Clark Corporation (KMB) stock move?

KMB rose 0.1% to $108.48. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did KMB stock rise?

KMB gained 0.12% ($0.13) versus the prior close of $108.35, last trading at $108.48 on 0.5× average volume.

When is Kimberly-Clark Corporation's next earnings date?

KMB's next earnings report is estimated for 2026-08-04 — about 14 days away.

What is the analyst price target for KMB?

The consensus analyst price target for KMB is $108.75, about 0.2% above the current $108.48. Over the past 90 days, analysts recorded 0 upgrades, 4 maintains, and 0 downgrades.

How BestStocks tracks KMB

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared KMB-specific materiality thresholds, triggering an evidence check. It draws on 7 tracked change events for KMB, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.